References
- Chou E, Pirruccello JP, Ellinor PT, Lindsay ME. Genetics and mechanisms of thoracic aortic disease. Nat Rev Cardiol. 2023;20(3):168-180. doi: 10.1038/s41569-022-00763-0
- Gao J, Cao H, Hu G, et al. The mechanism and therapy of aortic aneurysms. Sig Transduct Target Ther. 2023;8(1):55. doi: 10.1038/s41392-023-01325-7
- Isselbacher EM, Preventiza O, Black JH
III , et al. 2022 ACC/AHA Guideline for the Diagnosis and Management of Aortic Disease: A Report of the American Heart Association/American College of Cardiology Joint Committee on Clinical Practice Guidelines. Circulation. 2022 Dec 13;146(24):e334-e482. doi: 10.1161/CIR.0000000000001106 - Coady MA, Davies RR, Roberts M, et al. Familial patterns of thoracic aortic aneurysms. Arch Surg. 1999;134(4):361-367. doi: 10.1001/archsurg.134.4.361
- Thakker PD, Braverman AC. Cardiogenetics: genetic testing in the diagnosis and management of patients with aortic disease. Heart. 2021;107(8):619-626. doi: 10.1136/heartjnl-2020-317036
- Isselbacher EM, Lino Cardenas CL, Lindsay ME. Hereditary Influence in Thoracic Aortic Aneurysm and Dissection. Circulation. 2016;133(24):2516-2528. doi: 10.1161/CIRCULATIONAHA.116.009762
- Chou EL, Lindsay ME. The genetics of aortopathies: Hereditary thoracic aortic aneurysms and dissections. Am J Med Genet C Semin Med Genet. 2020;184(1):136-148. doi: 10.1002/ajmg.c.31771
- Renard M, Francis C, Ghosh R, et al. Clinical Validity of Genes for Heritable Thoracic Aortic Aneurysm and Dissection. JACC. 2018;72(6):605-615. doi: 10.1016/j.jacc.2018.04.089
- Takeda N, Hara H, Fujiwara T, Kanaya T, Maemura S, Komuro I. TGF-β Signaling-Related Genes and Thoracic Aortic Aneurysms and Dissections. Int J Mol Sci. 2018;19(7):2125. doi: 10.3390/ijms19072125
- Jones JA, Spinale FG, Ikonomidis JS. Transforming growth factor-beta signaling in thoracic aortic aneurysm development: a paradox in pathogenesis. J Vasc Res. 2009;46(2):119-137. doi: 10.1159/000151766
- Milewicz DM, Trybus KM, Guo DC, et al. Altered Smooth Muscle Cell Force Generation as a Driver of Thoracic Aortic Aneurysms and Dissections. Arterioscler Thromb Vasc Biol. 2017;37(1):26-34. doi: 10.1161/ATVBAHA.116.303229
- Dietz HC, Cutting CR, Pyeritz RE, et al. Marfan syndrome caused by a recurrent de novo missense mutation in the fibrillin gene. Nature. 1991;352(6333):337-339. doi: 10.1038/352337a0
- Judge DP, Dietz HC. Marfan’s syndrome. Lancet. 2005;366(9501):1965-1976. doi: 10.1016/S0140-6736(05)67789-6
- Neptune ER, Frischmeyer PA, Arking DE, et al. Dysregulation of TGF-beta activation contributes to pathogenesis in Marfan syndrome. Nat Genet. 2003;33(3):407-411. doi: 10.1038/ng1116
- Loeys BL, Dietz HC, Braverman AC, et al. The revised Ghent nosology for the Marfan syndrome. J Med Genet. 2010 Jul;47(7):476-485. doi: 10.1136/jmg.2009.072785
- Loeys BL, Chen J, Neptune ER, et al. A syndrome of altered cardiovascular, craniofacial, neurocognitive and skeletal development caused by mutations in TGFBR1 or TGFBR2. Nat Genet. 2005;37(3):275-281. doi: 10.1038/ng1511
- Loeys BL, Schwarze U, Holm T, et al. Aneurysm syndromes caused by mutations in the TGF-beta receptor. N Engl J Med. 2006;355(8):788-798. doi: 10.1056/NEJMoa055695
- Lindsay ME, Schepers D, Bolar NA, et al. Loss-of-function mutations in TGFB2 cause a syndromic presentation of thoracic aortic aneurysm. Nat Genet. 2012;44(8):922-927. doi: 10.1038/ng.2349
- Loeys BL, Dietz HC.
Loeys-Dietz Syndrome . In: Adam MP, Bick S, Mirzaa GM, Pagon RA, Wallace SE, Amemiya A, eds. GeneReviews®. Seattle, WA: University of Washington; 1993. Accessed June 5, 2026.https://www.ncbi.nlm.nih.gov/books/NBK1133/ - Pepin M, Schwarze U, Superti-Furga A, Byers PH. Clinical and genetic features of Ehlers-Danlos syndrome type IV, the vascular type. N Engl J Med. 2000;342(10):673-680. doi: 10.1056/NEJM200003093421001
- Shabani M, Abdollahi A, Brar BK, et al. Vascular aneurysms in Ehlers-Danlos syndrome subtypes: A systematic review. Clin Genet. 2023;103(3):261-267. doi: 10.1111/cge.14245
- Kaadan MI, MacDonald C, Ponzini F, et al. Prospective Cardiovascular Genetics Evaluation in Spontaneous Coronary Artery Dissection. Circ Genom Precis Med. 2018;11(4):
e001933 . doi: 10.1161/CIRCGENETICS.117.001933 - Wang Y, Starovoytov A, Murad AM, et al. Burden of Rare Genetic Variants in Spontaneous Coronary Artery Dissection With High-risk Features. JAMA Cardiol. 2022;7(10):1045-1055. doi: 10.1001/jamacardio.2022.2970
- Regalado ES, Mellor-Crummey L, De Backer J, et al. Clinical history and management recommendations of the smooth muscle dysfunction syndrome due to ACTA2 arginine 179 alterations. Genet Med. 2018;20(10):1206-1215. doi: 10.1038/gim.2017.245
- Carmignac V, Thevenon J, Adès L, et al. In-frame mutations in exon 1 of SKI cause dominant Shprintzen-Goldberg syndrome. Am J Hum Genet. 2012;91(5):950-957. doi: 10.1016/j.ajhg.2012.10.002
- Bouhatous YM, Arnaud P, Jondeau G, et al. Shprintzen-Goldberg syndrome: follow-up of the cardiovascular features in an international cohort of 29 patients with SGS. J Med Genet. 2025;62(9):600-606. doi: 10.1136/jmg-2024-110341
- Coucke PJ, Willaert A, Wessels MW, et al. Mutations in the facilitative glucose transporter GLUT10 alter angiogenesis and cause arterial tortuosity syndrome. Nat Genet. 2006;38(4):452-457. doi: 10.1038/ng1764
- Callewaert B, De Paepe A, Coucke P.
Arterial Tortuosity Syndrome . In: Adam MP, Bick S, Mirzaa GM, Pagon RA, Wallace SE, Amemiya A, eds. GeneReviews®. Seattle, WA: University of Washington; 1993. Accessed June 5, 2026.https://www.ncbi.nlm.nih.gov/books/NBK253404/ - Gómez-Garre P, Seijo M, Gutiérrez-Delicado E, et al. Ehlers-Danlos syndrome and periventricular nodular heterotopia in a Spanish family with a single FLNA mutation. J Med Genet. 2006;43(3):232-237. doi: 10.1136/jmg.2004.029173
- Sheen VL, Jansen A, Chen MH, et al. Filamin A mutations cause periventricular heterotopia with Ehlers-Danlos syndrome. Neurology. 2005;64(2):254-262. doi: 10.1212/01.WNL.0000149512.79621.DF
- Meester JAN, De Kinderen P, Verstraeten A, Loeys B. Meester-Loeys Syndrome. Adv Exp Med Biol. 2021;1348:265-272. doi: 10.1007/978-3-030-80614-9_12
- Meester JAN, Hebert A, Bastiaansen M, et al. Expanding the clinical spectrum of biglycan-related Meester-Loeys syndrome. NPJ Genom Med. 2024;9(1):22. doi: 10.1038/s41525-024-00413-z
- Van Gucht I, Krebsova A, Diness BR, et al. Novel LOX Variants in Five Families with Aortic/Arterial Aneurysm and Dissection with Variable Connective Tissue Findings. Int J Mol Sci. 2021;22(13):7111. doi: 10.3390/ijms22137111
- Guo D chuan, Regalado ES, Gong L, et al. LOX Mutations Predispose to Thoracic Aortic Aneurysms and Dissections. Circ Res. 2016;118(6):928-934. doi: 10.1161/CIRCRESAHA.115.307130
- Pannu H, Tran-Fadulu V, Papke CL, et al. MYH11 mutations result in a distinct vascular pathology driven by insulin-like growth factor 1 and angiotensin II. Hum Mol Genet. 2007;16(20):2453-2462. doi: 10.1093/hmg/ddm201
- Guo DC, Hostetler EM, Fan Y, et al. Heritable Thoracic Aortic Disease Genes in Sporadic Aortic Dissection. J Am Coll Cardiol. 2017;70(21):2728-2730. doi: 10.1016/j.jacc.2017.09.1094
- Velchev JD, Krebsová A, Votýpka P, et al. Genetic yield of targeted diagnostic screening in a large European cohort of 368 thoracic aortic dissection patients. Eur J Hum Genet. 2026 Jun 3. doi: 10.1038/s41431-026-02145-3
- Kwartler CS, Gong L, Chen J, et al. Variants of Unknown Significance in Genes Associated with Heritable Thoracic Aortic Disease Can Be Low Penetrant “Risk Variants.” Am J Hum Genet. 2018;103(1):138-143. doi: 10.1016/j.ajhg.2018.05.012
- Klarin D, Devineni P, Sendamarai AK, et al. Genome-wide association study of thoracic aortic aneurysm and dissection in the Million Veteran Program. Nat Genet. 2023;55(7):1106-1115. doi: 10.1038/s41588-023-01420-z
- Tcheandjieu C, Xiao K, Tejeda H, et al. High heritability of ascending aortic diameter and trans-ancestry prediction of thoracic aortic disease. Nat Genet. 2022;54(6):772-782. doi: 10.1038/s41588-022-01070-7
- Nekoui M, Pirruccello JP, Di Achille P, et al. Spatially Distinct Genetic Determinants of Aortic Dimensions Influence Risks of Aneurysm and Stenosis. J Am Coll Cardiol. 2022;80(5):486-497. doi: 10.1016/j.jacc.2022.05.024
- Pirruccello JP, Chaffin MD, Chou EL, et al. Deep learning enables genetic analysis of the human thoracic aorta. Nat Genet. 2022;54(1):40-51. doi: 10.1038/s41588-021-00962-4
- Francis CM, Futschik ME, Huang J, et al. Genome-wide associations of aortic distensibility suggest causality for aortic aneurysms and brain white matter hyperintensities. Nat Commun. 2022;13(1):4505. doi: 10.1038/s41467-022-32219-x
- Pirruccello JP, Khurshid S, Lin H, et al. The AORTA Gene score for detection and risk stratification of ascending aortic dilation. Eur Heart J. 2024;45(40):4318-4332. doi: 10.1093/eurheartj/ehae474
- Misra A, Jowell A, Haidermota S, et al. Development and Validation of a Clinical Polygenic Risk Report in U.S.-Based Health Systems for 8 Cardiovascular Conditions. J Am Coll Cardiol. 2026 Apr 29:S0735-1097(26)05809-2. doi: 10.1016/j.jacc.2026.03.035
- DePaolo J, Zamirpour S, Abramowitz S, et al. Predicting Thoracic Aortic Dissection in a Diverse Biobank Using a Polygenic Risk Score. JACC Adv. 2025;4(5):101743. doi: 10.1016/j.jacadv.2025.101743
- Xu Z, Li Z, Xiang L, et al. Phenotypic Diversity of Marfan Syndrome. JACC Adv. 2025;4(9):102051. doi: 10.1016/j.jacadv.2025.102051
- Koefoed AW, Huguenard AL, Johnson GW, et al. Characterization of Arterial Aneurysms in Loeys-Dietz Syndrome. JACC. 2025;85(24):2343-2352. doi: 10.1016/j.jacc.2025.04.020
- Abdul Nabi H, Dreher LA, Vandolah H, et al. Prevalence and predictors of extra-aortic aneurysms in Marfan syndrome. Heart. 2026 May 8:heartjnl-2025-327408. doi: 10.1136/heartjnl-2025-327408
- Lopez-Sainz A, Mila L, Rodriguez-Palomares J, et al. Aortic Branch Aneurysms and Vascular Risk in Patients With Marfan Syndrome. J Am Coll Cardiol. 2021;77(24):3005-3012. doi: 10.1016/j.jacc.2021.04.054
- Calderon-Martinez E, Velasco WV, Guo D, et al. Differences in Arterial Events in Vascular Ehlers-Danlos, Loeys-Dietz, and Marfan Syndrome. J Am Coll Cardiol. 2025;85(24):2355-2367. doi: 10.1016/j.jacc.2025.04.023
- Jeoffrey SMH, Kalyanasundaram A, Zafar MA, Ziganshin BA, Elefteriades JA. Genetic Overlap of Spontaneous Dissection of Either the Thoracic Aorta or the Coronary Arteries. Am J Cardiol. 2023;205:69-74. doi: 10.1016/j.amjcard.2023.07.046
- Wittenberg R, Gwynne C, Wong E, et al. Abstract 4357563: Genetic Testing Yield and Associations with Disease Phenotype for Thoracic, Coronary, Abdominal, and Cervical Aneurysms and Dissections. Circulation. 2025;152(Suppl_3):A4357563-A4357563. doi: 10.1161/circ.152.suppl_3.4357563
- Jabagi H, Shaw RE, Kontorovich AR, et al. Utilization of current ACC/AHA genetic testing recommendations for thoracic aortic disease at a large adult aortic center. Genet Med. 2026;28(4):102069. doi: 10.1016/j.gim.2026.102069
- Erez E, Acuna Higaki AR, Cupo M, et al. Clinical effectiveness of genetic testing guidelines in patients with thoracic aortic aneurysms. J Thorac Cardiovasc Surg. 2025;170(3):670-677.e3. doi: 10.1016/j.jtcvs.2024.09.026
- Brooke BS, Habashi JP, Judge DP, Patel N, Loeys B, Dietz HC. Angiotensin II Blockade and Aortic-Root Dilation in Marfan’s Syndrome. New Engl J Med. 2008 Jun 26;358(26):2787-2795. doi: 10.1056/NEJMoa0706585
- van Andel MM, Indrakusuma R, Jalalzadeh H, et al. Long-term clinical outcomes of losartan in patients with Marfan syndrome: follow-up of the multicentre randomized controlled COMPARE trial. Eur Heart J. 2020;41(43):4181-4187. doi: 10.1093/eurheartj/ehaa377
- Pitcher A, Spata E, Emberson J, et al. Angiotensin receptor blockers and β blockers in Marfan syndrome: an individual patient data meta-analysis of randomised trials. Lancet. 2022;400(10355):822-831. doi: 10.1016/S0140-6736(22)01534-3
- Ding Q, Gan P, Xu Z, et al. Genomic Editing of a Pathogenic Sequence Variant in ACTA2 Rescues Multisystemic Smooth Muscle Dysfunction Syndrome in Mice. Circulation. 2025;152(7):465-483. doi: 10.1161/CIRCULATIONAHA.125.074218
- Alves CRR, Das S, Krishnan V, et al. Treatment of a severe vascular disease using a bespoke CRISPR-Cas9 base editor in mice. Nat Biomed Eng. 2026;10(5):952-967. doi: 10.1038/s41551-025-01499-1
- Dietz H.
FBN1-Related Marfan Syndrome . In: Adam MP, Bick S, Mirzaa GM, Pagon RA, Wallace SE, Amemiya A, eds. GeneReviews®. Seattle, WA: University of Washington; 1993. Accessed June 5, 2026.https://www.ncbi.nlm.nih.gov/books/NBK1335/ - Demirdas S, van den Bersselaar LM, Lechner R, et al. Vascular Ehlers-Danlos Syndrome: A Comprehensive Natural History Study in a Dutch National Cohort of 142 Patients. Circ Genom Precis Med. 2024;17(3):
e003978 . doi: 10.1161/CIRCGEN.122.003978 - Greally MT.
Shprintzen-Goldberg Syndrome . In: Adam MP, Bick S, Mirzaa GM, Pagon RA, Wallace SE, Amemiya A, eds. GeneReviews®. Seattle, WA: University of Washington; 1993. Accessed June 5, 2026.https://www.ncbi.nlm.nih.gov/books/NBK1277/ - Meester JAN, Vandeweyer G, Pintelon I, et al. Loss-of-function mutations in the X-linked biglycan gene cause a severe syndromic form of thoracic aortic aneurysms and dissections. Genet Med. 2017;19(4):386-395. doi: 10.1038/gim.2016.126
DOI: https://doi.org/10.14797/mdcvj.1908 | Journal eISSN: 1947-6108
Language: English
Page range: 87 - 101
Submitted on: Jun 27, 2026
Accepted on: Aug 18, 2026
Published on: Sep 15, 2026
Published by: Houston Methodist DeBakey Heart & Vascular Center
In partnership with: Paradigm Publishing Services
© 2026 Rachel E. Wittenberg, Mark E. Lindsay, published by Houston Methodist DeBakey Heart & Vascular Center
This work is licensed under the Creative Commons Attribution-NonCommercial 4.0 License.